Gene therapy of metastatic colon carcinoma: Regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-03-01

AUTHORS

Andreas Block, Christian T F Freund, Shu-Hsia Chen, Khiem-Pham Nguyen, Milton Finegold, Eberhard Windler, Savio L C Woo

ABSTRACT

Colon carcinoma accounts for 20% of deaths due to malignancies in the Western world. Once metastases occur, therapeutic options are limited, with an approximate 5-year survival of only 5%. To investigate the potential of new gene therapeutic approaches, a hepatic micrometastasis model of colon carcinoma in BALB/c mice was established. Inoculation of syngeneic MCA26 colon carcinoma cells into the spleens of 18- to 20-week-old mice resulted in the formation of multiple hepatic metastases. Selective transduction of developing hepatic metastases was demonstrated using a β-galactosidase-expressing recombinant adenovirus. Cytosine deaminase (CD) can metabolize 5-fluorocytosine into the chemotherapeutic reagent 5-fluorouracil (5FU). The antitumoral potential of this suicide gene therapy approach was explored by systemic application of a recombinant replication-deficient adenovirus encoding for the bacterial CD gene under the control of the cytomegalovirus promoter (Ad.CMV-CD). Injection into the tail vein of tumor-bearing mice resulted in delayed tumor growth with significant reduction in hepatic metastases. The potential of this experimental approach for possible future clinical applications was evaluated by investigating adenoviral transduction efficiency, 5FU sensitivity, and 5-fluorocytosine-dependent Ad.CMV-CD toxicity in a variety of human colon cancer cell lines. Although the murine cell lines MCA26 and CC36 were highly sensitive to 5FU, the human colon cancer cell lines showed a 1–100 times higher resistance to 5FU. Specific Ad.CMV-CD toxicity correlates with 5FU toxicity. Transduction efficiency in human colon carcinoma cell lines was shown to be 10–1700 times higher compared with murine cell lines, thus compensating for 5FU resistance. In conclusion, suicide gene therapy using CD may be promising as an adjuvant treatment regimen for hepatic micrometastases of human colon carcinoma. More... »

PAGES

438-445

Journal

TITLE

Cancer Gene Therapy

ISSUE

3

VOLUME

7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.cgt.7700131

DOI

http://dx.doi.org/10.1038/sj.cgt.7700131

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030407045

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10766350


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenoviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bacterial Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colonic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytosine Deaminase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nucleoside Deaminases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, University Hospital Eppendorf, Hamburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.13648.38", 
          "name": [
            "Department of Medicine, University Hospital Eppendorf, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Block", 
        "givenName": "Andreas", 
        "id": "sg:person.0675006360.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675006360.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, Texas", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, Texas"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Freund", 
        "givenName": "Christian T F", 
        "id": "sg:person.01345371014.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345371014.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York", 
          "id": "http://www.grid.ac/institutes/grid.416167.3", 
          "name": [
            "Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Shu-Hsia", 
        "id": "sg:person.0757037242.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757037242.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York", 
          "id": "http://www.grid.ac/institutes/grid.416167.3", 
          "name": [
            "Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nguyen", 
        "givenName": "Khiem-Pham", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Baylor College of Medicine, 77030, Houston, Texas", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Department of Pathology, Baylor College of Medicine, 77030, Houston, Texas"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Finegold", 
        "givenName": "Milton", 
        "id": "sg:person.014103516477.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014103516477.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, University Hospital Eppendorf, Hamburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.13648.38", 
          "name": [
            "Department of Medicine, University Hospital Eppendorf, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Windler", 
        "givenName": "Eberhard", 
        "id": "sg:person.01252257010.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252257010.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York", 
          "id": "http://www.grid.ac/institutes/grid.416167.3", 
          "name": [
            "Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woo", 
        "givenName": "Savio L C", 
        "id": "sg:person.013131317422.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013131317422.28"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00256695", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003964230", 
          "https://doi.org/10.1007/bf00256695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00204750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030138404", 
          "https://doi.org/10.1007/bf00204750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0892-372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013197479", 
          "https://doi.org/10.1038/ng0892-372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0994-42", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049464160", 
          "https://doi.org/10.1038/ng0994-42"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1987.190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007170068", 
          "https://doi.org/10.1038/bjc.1987.190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01366937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031486449", 
          "https://doi.org/10.1007/bf01366937"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-03-01", 
    "datePublishedReg": "2000-03-01", 
    "description": "Colon carcinoma accounts for 20% of deaths due to malignancies in the Western world. Once metastases occur, therapeutic options are limited, with an approximate 5-year survival of only 5%. To investigate the potential of new gene therapeutic approaches, a hepatic micrometastasis model of colon carcinoma in BALB/c mice was established. Inoculation of syngeneic MCA26 colon carcinoma cells into the spleens of 18- to 20-week-old mice resulted in the formation of multiple hepatic metastases. Selective transduction of developing hepatic metastases was demonstrated using a \u03b2-galactosidase-expressing recombinant adenovirus. Cytosine deaminase (CD) can metabolize 5-fluorocytosine into the chemotherapeutic reagent 5-fluorouracil (5FU). The antitumoral potential of this suicide gene therapy approach was explored by systemic application of a recombinant replication-deficient adenovirus encoding for the bacterial CD gene under the control of the cytomegalovirus promoter (Ad.CMV-CD). Injection into the tail vein of tumor-bearing mice resulted in delayed tumor growth with significant reduction in hepatic metastases. The potential of this experimental approach for possible future clinical applications was evaluated by investigating adenoviral transduction efficiency, 5FU sensitivity, and 5-fluorocytosine-dependent Ad.CMV-CD toxicity in a variety of human colon cancer cell lines. Although the murine cell lines MCA26 and CC36 were highly sensitive to 5FU, the human colon cancer cell lines showed a 1\u2013100 times higher resistance to 5FU. Specific Ad.CMV-CD toxicity correlates with 5FU toxicity. Transduction efficiency in human colon carcinoma cell lines was shown to be 10\u20131700 times higher compared with murine cell lines, thus compensating for 5FU resistance. In conclusion, suicide gene therapy using CD may be promising as an adjuvant treatment regimen for hepatic micrometastases of human colon carcinoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.cgt.7700131", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1112008", 
        "issn": [
          "0929-1903", 
          "1476-5500"
        ], 
        "name": "Cancer Gene Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "multiple hepatic metastases", 
      "hepatic metastases", 
      "colon carcinoma", 
      "human colon cancer cell lines", 
      "colon cancer cell lines", 
      "cancer cell lines", 
      "cell lines", 
      "BALB/c mice", 
      "adjuvant treatment regimen", 
      "cytosine deaminase", 
      "metastatic colon carcinoma", 
      "tumor-bearing mice", 
      "recombinant replication-deficient adenovirus", 
      "possible future clinical applications", 
      "replication-deficient adenovirus", 
      "gene therapy", 
      "gene therapeutic approaches", 
      "suicide gene therapy", 
      "treatment regimen", 
      "therapeutic options", 
      "hepatic micrometastases", 
      "carcinoma cell lines", 
      "c mice", 
      "human colon carcinoma", 
      "micrometastasis model", 
      "therapeutic approaches", 
      "tail vein", 
      "human colon carcinoma cell line", 
      "future clinical applications", 
      "colon carcinoma cell line", 
      "colon carcinoma cells", 
      "gene therapy approaches", 
      "metastasis", 
      "tumor growth", 
      "suicide gene therapy approach", 
      "carcinoma", 
      "systemic application", 
      "bacterial cytosine deaminase", 
      "adenoviral transduction efficiency", 
      "chemotherapeutic reagents", 
      "carcinoma cells", 
      "recombinant adenovirus", 
      "mice", 
      "transduction efficiency", 
      "toxicity correlates", 
      "CD gene", 
      "murine cell lines", 
      "antitumoral potential", 
      "therapy approaches", 
      "clinical application", 
      "cytomegalovirus promoter", 
      "adenoviral expression", 
      "significant reduction", 
      "therapy", 
      "Western world", 
      "adenovirus", 
      "selective transduction", 
      "toxicity", 
      "regimen", 
      "micrometastases", 
      "malignancy", 
      "spleen", 
      "deaminase", 
      "death", 
      "CC36", 
      "survival", 
      "vein", 
      "injection", 
      "correlates", 
      "conclusion", 
      "cells", 
      "resistance", 
      "regression", 
      "options", 
      "expression", 
      "lines", 
      "inoculation", 
      "potential", 
      "control", 
      "genes", 
      "high resistance", 
      "transduction", 
      "sensitivity", 
      "reduction", 
      "promoter", 
      "experimental approach", 
      "time", 
      "approach", 
      "AD", 
      "growth", 
      "variety", 
      "model", 
      "formation", 
      "reagents", 
      "world", 
      "times higher resistance", 
      "applications", 
      "efficiency"
    ], 
    "name": "Gene therapy of metastatic colon carcinoma: Regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase", 
    "pagination": "438-445", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030407045"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.cgt.7700131"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10766350"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.cgt.7700131", 
      "https://app.dimensions.ai/details/publication/pub.1030407045"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_324.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.cgt.7700131"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700131'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700131'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700131'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700131'


 

This table displays all metadata directly associated to this object as RDF triples.

292 TRIPLES      21 PREDICATES      144 URIs      130 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.cgt.7700131 schema:about N018a87b25e6b4b018cc185f5a4d9c77e
2 N19d1ac40b6474fd889b9243afff0fc4e
3 N1d7c4e67a0ed4aa5bb750f97c5fae6e4
4 N23632220465f4a789dc086f75d531751
5 N3ff35e014fd848dca361f6f14c104aa7
6 N540a9541612d4810a22860c81d6216ae
7 N5757f887f0a94df08d21a8c4a3956316
8 N646be081f83e41649109e21b25b47cf5
9 N6668745f1408432484804636fa948d70
10 N8260f39db71c424daed4d1f326dcdeb4
11 Na1ba5cea3e7046c4a96c268fda672dba
12 Nc87ddb1b14464438b2e3a50deaab42e8
13 Nd0149bbc89714a439956b5e298db9cba
14 Nd82ff358f7574ba99da4eee7243e3915
15 Nf267537c79084fab9d437bad124ab04f
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N3ba43ba1e2a14e38b4c1aec4ea36baf8
19 schema:citation sg:pub.10.1007/bf00204750
20 sg:pub.10.1007/bf00256695
21 sg:pub.10.1007/bf01366937
22 sg:pub.10.1038/bjc.1987.190
23 sg:pub.10.1038/ng0892-372
24 sg:pub.10.1038/ng0994-42
25 schema:datePublished 2000-03-01
26 schema:datePublishedReg 2000-03-01
27 schema:description Colon carcinoma accounts for 20% of deaths due to malignancies in the Western world. Once metastases occur, therapeutic options are limited, with an approximate 5-year survival of only 5%. To investigate the potential of new gene therapeutic approaches, a hepatic micrometastasis model of colon carcinoma in BALB/c mice was established. Inoculation of syngeneic MCA26 colon carcinoma cells into the spleens of 18- to 20-week-old mice resulted in the formation of multiple hepatic metastases. Selective transduction of developing hepatic metastases was demonstrated using a β-galactosidase-expressing recombinant adenovirus. Cytosine deaminase (CD) can metabolize 5-fluorocytosine into the chemotherapeutic reagent 5-fluorouracil (5FU). The antitumoral potential of this suicide gene therapy approach was explored by systemic application of a recombinant replication-deficient adenovirus encoding for the bacterial CD gene under the control of the cytomegalovirus promoter (Ad.CMV-CD). Injection into the tail vein of tumor-bearing mice resulted in delayed tumor growth with significant reduction in hepatic metastases. The potential of this experimental approach for possible future clinical applications was evaluated by investigating adenoviral transduction efficiency, 5FU sensitivity, and 5-fluorocytosine-dependent Ad.CMV-CD toxicity in a variety of human colon cancer cell lines. Although the murine cell lines MCA26 and CC36 were highly sensitive to 5FU, the human colon cancer cell lines showed a 1–100 times higher resistance to 5FU. Specific Ad.CMV-CD toxicity correlates with 5FU toxicity. Transduction efficiency in human colon carcinoma cell lines was shown to be 10–1700 times higher compared with murine cell lines, thus compensating for 5FU resistance. In conclusion, suicide gene therapy using CD may be promising as an adjuvant treatment regimen for hepatic micrometastases of human colon carcinoma.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf N039b7fc0b6894dd1afd333d1d66f269d
31 N251d6b31493b450688325e29dfbf3e62
32 sg:journal.1112008
33 schema:keywords AD
34 BALB/c mice
35 CC36
36 CD gene
37 Western world
38 adenoviral expression
39 adenoviral transduction efficiency
40 adenovirus
41 adjuvant treatment regimen
42 antitumoral potential
43 applications
44 approach
45 bacterial cytosine deaminase
46 c mice
47 cancer cell lines
48 carcinoma
49 carcinoma cell lines
50 carcinoma cells
51 cell lines
52 cells
53 chemotherapeutic reagents
54 clinical application
55 colon cancer cell lines
56 colon carcinoma
57 colon carcinoma cell line
58 colon carcinoma cells
59 conclusion
60 control
61 correlates
62 cytomegalovirus promoter
63 cytosine deaminase
64 deaminase
65 death
66 efficiency
67 experimental approach
68 expression
69 formation
70 future clinical applications
71 gene therapeutic approaches
72 gene therapy
73 gene therapy approaches
74 genes
75 growth
76 hepatic metastases
77 hepatic micrometastases
78 high resistance
79 human colon cancer cell lines
80 human colon carcinoma
81 human colon carcinoma cell line
82 injection
83 inoculation
84 lines
85 malignancy
86 metastasis
87 metastatic colon carcinoma
88 mice
89 micrometastases
90 micrometastasis model
91 model
92 multiple hepatic metastases
93 murine cell lines
94 options
95 possible future clinical applications
96 potential
97 promoter
98 reagents
99 recombinant adenovirus
100 recombinant replication-deficient adenovirus
101 reduction
102 regimen
103 regression
104 replication-deficient adenovirus
105 resistance
106 selective transduction
107 sensitivity
108 significant reduction
109 spleen
110 suicide gene therapy
111 suicide gene therapy approach
112 survival
113 systemic application
114 tail vein
115 therapeutic approaches
116 therapeutic options
117 therapy
118 therapy approaches
119 time
120 times higher resistance
121 toxicity
122 toxicity correlates
123 transduction
124 transduction efficiency
125 treatment regimen
126 tumor growth
127 tumor-bearing mice
128 variety
129 vein
130 world
131 schema:name Gene therapy of metastatic colon carcinoma: Regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase
132 schema:pagination 438-445
133 schema:productId N73bf99281bc741bbb84a3d927ab056d0
134 N7c7e10b6e83a4cf98c67faad2590f030
135 Nba76b501481944bf8040d0a0f037d84d
136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030407045
137 https://doi.org/10.1038/sj.cgt.7700131
138 schema:sdDatePublished 2022-12-01T06:22
139 schema:sdLicense https://scigraph.springernature.com/explorer/license/
140 schema:sdPublisher N54afa1c245f44431ad10b13c5e678d85
141 schema:url https://doi.org/10.1038/sj.cgt.7700131
142 sgo:license sg:explorer/license/
143 sgo:sdDataset articles
144 rdf:type schema:ScholarlyArticle
145 N018a87b25e6b4b018cc185f5a4d9c77e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Mice
147 rdf:type schema:DefinedTerm
148 N039b7fc0b6894dd1afd333d1d66f269d schema:issueNumber 3
149 rdf:type schema:PublicationIssue
150 N19d1ac40b6474fd889b9243afff0fc4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Dose-Response Relationship, Drug
152 rdf:type schema:DefinedTerm
153 N1d7c4e67a0ed4aa5bb750f97c5fae6e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Liver Neoplasms
155 rdf:type schema:DefinedTerm
156 N23632220465f4a789dc086f75d531751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Nucleoside Deaminases
158 rdf:type schema:DefinedTerm
159 N251d6b31493b450688325e29dfbf3e62 schema:volumeNumber 7
160 rdf:type schema:PublicationVolume
161 N2956222aa3fb49d0841e6a03acf2cdd7 rdf:first Ndba81113c95e4d4b9cc32be626c76fc0
162 rdf:rest N4145e8c7cb244b8eb91c90d08ce9487e
163 N3ba43ba1e2a14e38b4c1aec4ea36baf8 rdf:first sg:person.0675006360.44
164 rdf:rest Nd2afb71f26924455b090396ae53a2bd5
165 N3ff35e014fd848dca361f6f14c104aa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Remission Induction
167 rdf:type schema:DefinedTerm
168 N4145e8c7cb244b8eb91c90d08ce9487e rdf:first sg:person.014103516477.24
169 rdf:rest Na74e44d0fd114e8a9b723cd1f0db4fdc
170 N540a9541612d4810a22860c81d6216ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Colonic Neoplasms
172 rdf:type schema:DefinedTerm
173 N54afa1c245f44431ad10b13c5e678d85 schema:name Springer Nature - SN SciGraph project
174 rdf:type schema:Organization
175 N5757f887f0a94df08d21a8c4a3956316 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Bacterial Proteins
177 rdf:type schema:DefinedTerm
178 N646be081f83e41649109e21b25b47cf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Fluorouracil
180 rdf:type schema:DefinedTerm
181 N6668745f1408432484804636fa948d70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Female
183 rdf:type schema:DefinedTerm
184 N73bf99281bc741bbb84a3d927ab056d0 schema:name dimensions_id
185 schema:value pub.1030407045
186 rdf:type schema:PropertyValue
187 N7c7e10b6e83a4cf98c67faad2590f030 schema:name pubmed_id
188 schema:value 10766350
189 rdf:type schema:PropertyValue
190 N8260f39db71c424daed4d1f326dcdeb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Animals
192 rdf:type schema:DefinedTerm
193 N8ee145d61ce14ea38c1b7a76eb5daefa rdf:first sg:person.013131317422.28
194 rdf:rest rdf:nil
195 Na1ba5cea3e7046c4a96c268fda672dba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Cytosine Deaminase
197 rdf:type schema:DefinedTerm
198 Na74e44d0fd114e8a9b723cd1f0db4fdc rdf:first sg:person.01252257010.27
199 rdf:rest N8ee145d61ce14ea38c1b7a76eb5daefa
200 Nb7dd3e791a0449cab08785aec20fb24c rdf:first sg:person.0757037242.50
201 rdf:rest N2956222aa3fb49d0841e6a03acf2cdd7
202 Nba76b501481944bf8040d0a0f037d84d schema:name doi
203 schema:value 10.1038/sj.cgt.7700131
204 rdf:type schema:PropertyValue
205 Nc87ddb1b14464438b2e3a50deaab42e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Adenoviridae
207 rdf:type schema:DefinedTerm
208 Nd0149bbc89714a439956b5e298db9cba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Genetic Therapy
210 rdf:type schema:DefinedTerm
211 Nd2afb71f26924455b090396ae53a2bd5 rdf:first sg:person.01345371014.52
212 rdf:rest Nb7dd3e791a0449cab08785aec20fb24c
213 Nd82ff358f7574ba99da4eee7243e3915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Mice, Inbred BALB C
215 rdf:type schema:DefinedTerm
216 Ndba81113c95e4d4b9cc32be626c76fc0 schema:affiliation grid-institutes:grid.416167.3
217 schema:familyName Nguyen
218 schema:givenName Khiem-Pham
219 rdf:type schema:Person
220 Nf267537c79084fab9d437bad124ab04f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Humans
222 rdf:type schema:DefinedTerm
223 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
224 schema:name Medical and Health Sciences
225 rdf:type schema:DefinedTerm
226 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
227 schema:name Oncology and Carcinogenesis
228 rdf:type schema:DefinedTerm
229 sg:journal.1112008 schema:issn 0929-1903
230 1476-5500
231 schema:name Cancer Gene Therapy
232 schema:publisher Springer Nature
233 rdf:type schema:Periodical
234 sg:person.01252257010.27 schema:affiliation grid-institutes:grid.13648.38
235 schema:familyName Windler
236 schema:givenName Eberhard
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252257010.27
238 rdf:type schema:Person
239 sg:person.013131317422.28 schema:affiliation grid-institutes:grid.416167.3
240 schema:familyName Woo
241 schema:givenName Savio L C
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013131317422.28
243 rdf:type schema:Person
244 sg:person.01345371014.52 schema:affiliation grid-institutes:grid.39382.33
245 schema:familyName Freund
246 schema:givenName Christian T F
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345371014.52
248 rdf:type schema:Person
249 sg:person.014103516477.24 schema:affiliation grid-institutes:grid.39382.33
250 schema:familyName Finegold
251 schema:givenName Milton
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014103516477.24
253 rdf:type schema:Person
254 sg:person.0675006360.44 schema:affiliation grid-institutes:grid.13648.38
255 schema:familyName Block
256 schema:givenName Andreas
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675006360.44
258 rdf:type schema:Person
259 sg:person.0757037242.50 schema:affiliation grid-institutes:grid.416167.3
260 schema:familyName Chen
261 schema:givenName Shu-Hsia
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757037242.50
263 rdf:type schema:Person
264 sg:pub.10.1007/bf00204750 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030138404
265 https://doi.org/10.1007/bf00204750
266 rdf:type schema:CreativeWork
267 sg:pub.10.1007/bf00256695 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003964230
268 https://doi.org/10.1007/bf00256695
269 rdf:type schema:CreativeWork
270 sg:pub.10.1007/bf01366937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031486449
271 https://doi.org/10.1007/bf01366937
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/bjc.1987.190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007170068
274 https://doi.org/10.1038/bjc.1987.190
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/ng0892-372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013197479
277 https://doi.org/10.1038/ng0892-372
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/ng0994-42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049464160
280 https://doi.org/10.1038/ng0994-42
281 rdf:type schema:CreativeWork
282 grid-institutes:grid.13648.38 schema:alternateName Department of Medicine, University Hospital Eppendorf, Hamburg, Germany
283 schema:name Department of Medicine, University Hospital Eppendorf, Hamburg, Germany
284 rdf:type schema:Organization
285 grid-institutes:grid.39382.33 schema:alternateName Department of Pathology, Baylor College of Medicine, 77030, Houston, Texas
286 Scott Department of Urology, Baylor College of Medicine, 77030, Houston, Texas
287 schema:name Department of Pathology, Baylor College of Medicine, 77030, Houston, Texas
288 Scott Department of Urology, Baylor College of Medicine, 77030, Houston, Texas
289 rdf:type schema:Organization
290 grid-institutes:grid.416167.3 schema:alternateName Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York
291 schema:name Institute for Gene Therapy, Mount Sinai Medical Center, 10029, New York, New York
292 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...